KALENITE CAPSULES
KALENITE CAPSULES
Discontinued
DIN Number
02011050
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
yerba prima
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02011050
AIG Number0334863001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB CONTACT LAXATIVES
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
ALDER BUCKTHORNActive
Strength: 12 MG / CAP
Monograph: ALDER BUCKTHORN
CLOVEActive
Strength: 33 MG / CAP
Monograph: CLOVE
YELLOW DOCKActive
Strength: 172 MG / CAP
Monograph: YELLOW DOCK